Low-dose follicle stimulating hormone (FSH) regimens have succeeded in reducing the rate of multiple pregnancies to 2–6 % and the rate of ovarian hyperstimulation syndrome (OHSS), as well [23]. This evidence concerns the gene BRD2 and ovarian hyperstimulation syndrome.